 | • レポートコード：QYR9ST08564 • 出版社/出版日：QYResearch / 2019年9月5日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥511,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,022,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、院内感染肺炎薬パイプライン分析の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、リン酸テジゾリド、セフトロザン/タゾバクタム、セフタジジム/アビバクタム、アミカシン吸入、プラゾミシン、シンフロリックスワクチンに、用途別には、細菌性肺炎、ウイルス性肺炎にセグメント区分し、院内感染肺炎薬パイプライン分析の世界市場を分析しました。 ・エグゼクティブ・サマリー ・院内感染肺炎薬パイプライン分析の世界市場概要 ・院内感染肺炎薬パイプライン分析の製造コスト構成分析 ・院内感染肺炎薬パイプライン分析の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・院内感染肺炎薬パイプライン分析の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・院内感染肺炎薬パイプライン分析のセグメント分析（種類別） （リン酸テジゾリド、セフトロザン/タゾバクタム、セフタジジム/アビバクタム、アミカシン吸入、プラゾミシン、シンフロリックスワクチン） ・院内感染肺炎薬パイプライン分析のセグメント分析（用途別） （細菌性肺炎、ウイルス性肺炎） ・院内感染肺炎薬パイプライン分析の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Achaogen、Aridis Pharmaceuticals、AstraZeneca、Cubist Pharmaceuticals、Meiji Seika Pharma、Merck、Sanofi、GlaxoSmithKline、Valneva） ・院内感染肺炎薬パイプライン分析の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat. Pneumonia is one of the prominent infections caused in hospital premises. Cases of hospital acquired pneumonia are common in immunocompromised patients, post surgical infections, enteral feeding, elderly and infant patients. As hospital acquired pneumonia is mainly caused as a result of prolonged exposure to ventilator air, it is also called as ventilator associated pneumonia. Major causative pathogens include methicillin resistant S. aureus (MRSA), multi drug resistant (MDR) P. aeruginosa, Klebsiella and Acinetobacter. Respiratory Syncytial Virus (RSV) has also been found to be a major causative agent of nosocomial pneumonia in new borne.
The global Pipeline Analysis of Hospital Acquired Pneumonia Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pipeline Analysis of Hospital Acquired Pneumonia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pipeline Analysis of Hospital Acquired Pneumonia Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pipeline Analysis of Hospital Acquired Pneumonia Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pipeline Analysis of Hospital Acquired Pneumonia Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Achaogen
Aridis Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
Meiji Seika Pharma
Merck
Sanofi
GlaxoSmithKline
Valneva
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tedizolid Phosphate
Ceftolozane/Tazobactam
Ceftazidime/Avibactum
Amikacin Inhale
Plazomicin
Synflorix Vaccine
Segment by Application
Bacterial Pneumonia
Viral Pneumonia
Table of Contents
Executive Summary
1 Industry Overview of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
1.1 Definition of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
1.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Segment by Type
1.2.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tedizolid Phosphate
1.2.3 Ceftolozane/Tazobactam
1.2.4 Ceftazidime/Avibactum
1.2.5 Amikacin Inhale
1.2.6 Plazomicin
1.2.7 Synflorix Vaccine
1.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Segment by Applications
1.3.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Bacterial Pneumonia
1.3.3 Viral Pneumonia
1.4 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Overall Market
1.4.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (2014-2025)
1.4.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (2014-2025)
1.4.3 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Status and Prospect (2014-2025)
1.4.4 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Status and Prospect (2014-2025)
1.4.5 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Status and Prospect (2014-2025)
1.4.6 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Status and Prospect (2014-2025)
1.4.8 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
2.3 Manufacturing Process Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
2.4 Industry Chain Structure of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
3 Development and Manufacturing Plants Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production and Capacity Analysis
4.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Analysis
4.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Price Analysis
4.4 Market Concentration Degree
5 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Regional Market Analysis
5.1 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production by Regions
5.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production by Regions
5.1.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Regions
5.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Regions
5.3 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis
5.3.1 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production
5.3.2 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export
5.4 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis
5.4.1 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production
5.4.2 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export
5.5 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis
5.5.1 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production
5.5.2 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export
5.6 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis
5.6.1 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production
5.6.2 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export
5.7 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis
5.7.1 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production
5.7.2 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export
5.8 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis
5.8.1 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production
5.8.2 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Import and Export
6 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Segment Market Analysis (by Type)
6.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production by Type
6.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Type
6.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Price by Type
7 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Segment Market Analysis (by Application)
7.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Application
7.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2014-2019)
8 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Major Manufacturers Analysis
8.1 Achaogen
8.1.1 Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.1.2 Achaogen Product Introduction, Application and Specification
8.1.3 Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Aridis Pharmaceuticals
8.2.1 Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.2.2 Aridis Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cubist Pharmaceuticals
8.4.1 Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.4.2 Cubist Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Meiji Seika Pharma
8.5.1 Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.5.2 Meiji Seika Pharma Product Introduction, Application and Specification
8.5.3 Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck
8.6.1 Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.6.2 Merck Product Introduction, Application and Specification
8.6.3 Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi
8.7.1 Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.7.2 Sanofi Product Introduction, Application and Specification
8.7.3 Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
8.8.3 GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Valneva
8.9.1 Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
8.9.2 Valneva Product Introduction, Application and Specification
8.9.3 Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market
9.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Trend Analysis
9.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Regional Market Trend
9.2.1 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast 2019-2025
9.2.2 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast 2019-2025
9.2.3 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast 2019-2025
9.2.4 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast 2019-2025
9.2.5 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast 2019-2025
9.2.6 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast 2019-2025
9.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Trend (Product Type)
9.4 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share by Types in 2018
Figure Tedizolid Phosphate Product Picture
Figure Ceftolozane/Tazobactam Product Picture
Figure Ceftazidime/Avibactum Product Picture
Figure Amikacin Inhale Product Picture
Figure Plazomicin Product Picture
Figure Synflorix Vaccine Product Picture
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Market Share by Applications in 2018
Figure Bacterial Pneumonia
Figure Viral Pneumonia
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Million USD) (2014-2025)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units) (2014-2025)
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Million USD) (2014-2025)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Million USD) (2014-2025)
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Million USD) (2014-2025)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Million USD) (2014-2025)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Size (Million USD) (2014-2025)
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs in 2018
Figure Manufacturing Process Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
Figure Industry Chain Structure of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturing Plants Distribution
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Share by Manufacturers in 2018
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Share by Manufacturers in 2018
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production by Regions 2014-2019 (K Units)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share by Regions 2014-2019
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share by Regions in 2018
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Regions 2014-2019
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Regions in 2018
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Market Share by Regions 2014-2019
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Consumption Import and Export (K Units)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Consumption Import and Export (K Units)
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Consumption Import and Export (K Units)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Consumption Import and Export (K Units)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share by Application (2014-2019)
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Sites and Area Served
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Introduction, Application and Specification
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate (2014-2019)
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Market Share (2014-2019)
Figure Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share (2014-2019)
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Main Business and Markets Served
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Application (2019-2025)
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Distributors List
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
院内感染肺炎予防の世界市場：インサイト・予測 HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…- 院内感染（HAI）診断の世界市場：市場規模・現状・予測 Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populatio…
- 院内感染制御の世界市場：市場規模・現状・予測 A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility.The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection…
- 院内感染治療の世界市場：市場規模・現状・予測 Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. In 2018, the global Hospital Acquired Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2…
- CINV既存・パイプライン薬の世界市場：インサイト・予測 Nausea and vomiting are the two most common side effects associated with cancer chemotherapy, and are referred to as chemotherapy induced nausea and vomiting (CINV).The global CINV Existing and Pipeline Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025…